Your browser doesn't support javascript.
loading
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.
Asa, Sylvia L; Mete, Ozgur; Cusimano, Michael D; McCutcheon, Ian E; Perry, Arie; Yamada, Shozo; Nishioka, Hiroshi; Casar-Borota, Olivera; Uccella, Silvia; La Rosa, Stefano; Grossman, Ashley B; Ezzat, Shereen.
Afiliação
  • Asa SL; Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA. Pathlady01@gmail.com.
  • Mete O; Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Cusimano MD; Department of Neurosurgery, Saint Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Perry A; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  • Yamada S; Hypothalamic and Pituitary Center, Moriyama Neurological Center Hospital, Tokyo, Japan.
  • Nishioka H; Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan.
  • Casar-Borota O; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Uccella S; Department of Pathology, University of Insubria, Varese, Italy.
  • La Rosa S; Institute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Grossman AB; Department of Endocrinology, University of Oxford, London, UK.
  • Ezzat S; Royal Free London, London, UK.
Mod Pathol ; 34(9): 1634-1650, 2021 09.
Article em En | MEDLINE | ID: mdl-34017065
ABSTRACT
The classification of adenohypophysial neoplasms as "pituitary neuroendocrine tumors" (PitNETs) was proposed in 2017 to reflect their characteristics as epithelial neuroendocrine neoplasms with a spectrum of clinical behaviors ranging from small indolent lesions to large, locally invasive, unresectable tumors. Tumor growth and hormone hypersecretion cause significant morbidity and mortality in a subset of patients. The proposal was endorsed by a WHO working group that sought to provide a unified approach to neuroendocrine neoplasia in all body sites. We review the features that are characteristic of neuroendocrine cells, the epidemiology and prognosis of these tumors, as well as further refinements in terms used for other pituitary tumors to ensure consistency with the WHO framework. The intense study of PitNETs has provided information about the importance of cellular differentiation in tumor prognosis as a model for neuroendocrine tumors in different locations.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article